1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Competitor Analysis: Anti-Obesity Peptides and Biologics

Product description

The present Competitive Intelligence Report about Anti-Obesity Peptides and Biologics used to treat obesity and metabolic syndrome provides a competitor evaluation in the field of R&D projects with anti-obesity peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. The database also contains information about discontinued projects. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of anti-obesity peptides and biologics such as proteins, antibodies, vaccines, cells, and RNA. In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing information on:
-Drug Codes,
-Target / Mechanism of Action,
-Class of Compound,
-Company,
-Product Category,
-Indication,
-R&D Stage and
-additional comments with a hyperlink leading to the source of information. 

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. 

Table Of Contents

Competitor Analysis: Anti-Obesity Peptides and Biologics
Table of Contents

--Obesity Peptides
-Anti-Obesity Biologics
-Corporate RandD Pipelines of Anti-Obesity Peptides and Biologics
-About La Merie

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025

Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025

  • $ 2 676
  • Industry report
  • May 2015
  • by Visiongain

Report Details Emerging Biological Drugs – This New Study Reveals Selling Opportunities and Revenue Prospects to Help You Stay Ahead What’s the future of biologics, especially new drug classes? Get ...

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • May 2015
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2015’, provides an overview of the Cytomegalovirus ...

Diphtheria - Pipeline Review, H1 2015

Diphtheria - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • June 2015
  • by Global Markets Direct

Diphtheria - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diphtheria - Pipeline Review, H1 2015’, provides an overview of the Diphtheria’s therapeutic pipeline. This report provides ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.